This technology is currently unpublished at the request of the university.
Novel Vaccine Components for Whooping Cough
Novel Toll-like receptor 2 agonists could be used for the development of a more effective vaccine for Whooping Cough
- A priority patent has been filed with the European Patent Office EP14160791.1
- Patent application submitted